Iman Iskander

1.3k total citations
25 papers, 892 citations indexed

About

Iman Iskander is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Iman Iskander has authored 25 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pediatrics, Perinatology and Child Health, 19 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Iman Iskander's work include Neonatal Health and Biochemistry (17 papers), Methemoglobinemia and Tumor Lysis Syndrome (14 papers) and Neonatal and fetal brain pathology (6 papers). Iman Iskander is often cited by papers focused on Neonatal Health and Biochemistry (17 papers), Methemoglobinemia and Tumor Lysis Syndrome (14 papers) and Neonatal and fetal brain pathology (6 papers). Iman Iskander collaborates with scholars based in Egypt, United States and Italy. Iman Iskander's co-authors include Richard P. Wennberg, Iman Seoud, Aleksandr Y. Aravkin, Chiara Greco, Carlos D. Coda Zabetta, Claudio Tiribelli, N Y Boo, Moataza Bashir, Bolajoko O. Olusanya and Paul D. Sampson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Iman Iskander

25 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iman Iskander Egypt 15 709 376 275 196 87 25 892
Okan Özcan Türkiye 16 308 0.4× 150 0.4× 70 0.3× 108 0.6× 9 0.1× 56 773
Thomas R. Boggs United States 17 526 0.7× 409 1.1× 153 0.6× 82 0.4× 9 0.1× 43 956
J. P. Farriaux France 14 130 0.2× 109 0.3× 137 0.5× 28 0.1× 24 0.3× 55 606
Juan J. Gershanik United States 12 151 0.2× 92 0.2× 78 0.3× 121 0.6× 14 0.2× 21 624
Swasti Chaturvedi Australia 14 141 0.2× 80 0.2× 83 0.3× 21 0.1× 69 0.8× 36 537
Rajiv Goel India 22 605 0.9× 658 1.8× 77 0.3× 21 0.1× 13 0.1× 55 1.2k
Alejandro Pérez‐Muñuzuri Spain 12 180 0.3× 161 0.4× 60 0.2× 13 0.1× 10 0.1× 56 443
Eva Mildenberger Germany 17 292 0.4× 409 1.1× 178 0.6× 22 0.1× 4 0.0× 94 915
Jens Drube Germany 16 175 0.2× 73 0.2× 120 0.4× 14 0.1× 23 0.3× 33 662
Anne Vierzig Germany 14 102 0.1× 491 1.3× 159 0.6× 14 0.1× 6 0.1× 30 848

Countries citing papers authored by Iman Iskander

Since Specialization
Citations

This map shows the geographic impact of Iman Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Iskander more than expected).

Fields of papers citing papers by Iman Iskander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Iskander. The network helps show where Iman Iskander may publish in the future.

Co-authorship network of co-authors of Iman Iskander

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Iskander. A scholar is included among the top collaborators of Iman Iskander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Iskander. Iman Iskander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iskander, Iman, et al.. (2021). Intensive phototherapy and oxidant-antioxidant status in infants with jaundice. Early Human Development. 161. 105465–105465. 6 indexed citations
2.
Iskander, Iman, et al.. (2020). Acute bilirubin encephalopathy: Some lessons learned. Seminars in Perinatology. 45(1). 151353–151353. 14 indexed citations
3.
Iskander, Iman, et al.. (2019). The spectrum of bilirubin neurotoxicity in term and near-term babies with hyperbilirubinemia: Does outcome improve with time?. Early Human Development. 140. 104909–104909. 15 indexed citations
4.
Iskander, Iman, et al.. (2018). Neonatal RBC transfusions: Do benefits outweigh risks?. Transfusion and Apheresis Science. 57(3). 431–436. 7 indexed citations
5.
Greco, Chiara, Iman Iskander, Rinawati Rohsiswatmo, et al.. (2018). Diagnostic Performance Analysis of the Point-of-Care Bilistick System in Identifying Severe Neonatal Hyperbilirubinemia by a Multi-Country Approach. EClinicalMedicine. 1. 14–20. 20 indexed citations
6.
Greco, Chiara, Iman Iskander, Giorgio Bedogni, et al.. (2017). Comparison between Bilistick System and transcutaneous bilirubin in assessing total bilirubin serum concentration in jaundiced newborns. Journal of Perinatology. 37(9). 1028–1031. 23 indexed citations
7.
8.
Iskander, Iman, et al.. (2017). Prediction of 3- to 5-Month Outcomes from Signs of Acute Bilirubin Toxicity in Newborn Infants. The Journal of Pediatrics. 183. 51–55.e1. 17 indexed citations
9.
Olusanya, Bolajoko O., Iman Iskander, Tina M. Slusher, & Richard P. Wennberg. (2016). A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings. Journal of Perinatology. 36(5). 338–341. 8 indexed citations
10.
Greco, Chiara, Gaston Arnolda, N Y Boo, et al.. (2016). Neonatal Jaundice in Low- and Middle-Income Countries: Lessons and Future Directions from the 2015 Don Ostrow Trieste Yellow Retreat. Neonatology. 110(3). 172–180. 127 indexed citations
11.
Olusanya, Bolajoko O., Tinuade A Ogunlesi, Praveen Kumar, et al.. (2015). Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings. BMC Pediatrics. 15(1). 39–39. 86 indexed citations
12.
Olusanya, Bolajoko O., Zainab Imam, Abieyuwa A. Emokpae, & Iman Iskander. (2015). Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings. Neonatology. 109(2). 97–104. 16 indexed citations
13.
Iskander, Iman, et al.. (2014). Serum Bilirubin and Bilirubin/Albumin Ratio as Predictors of Bilirubin Encephalopathy. PEDIATRICS. 134(5). e1330–e1339. 76 indexed citations
14.
Iskander, Iman, et al.. (2012). Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt. Eastern Mediterranean Health Journal. 18(8). 882–887. 38 indexed citations
15.
Zabetta, Carlos D. Coda, Iman Iskander, Chiara Greco, et al.. (2012). Bilistick: A Low-Cost Point-of-Care System to Measure Total Plasma Bilirubin. Neonatology. 103(3). 177–181. 50 indexed citations
16.
Risso, Francesco Maria, Laura D. Serpero, Luc J. I. Zimmermann, et al.. (2011). Perinatal asphyxia: Kidney failure does not affect S100B urine concentrations. Clinica Chimica Acta. 413(1-2). 150–153. 12 indexed citations
17.
El-Garf, Ayman, et al.. (2009). MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatology International. 30(10). 1293–1298. 29 indexed citations
18.
Gazzolo, Diego, Alessandro Frigiola, Moataza Bashir, et al.. (2009). Diagnostic Accuracy of S100B Urinary Testing at Birth in Full-Term Asphyxiated Newborns to Predict Neonatal Death. PLoS ONE. 4(2). e4298–e4298. 51 indexed citations
19.
Florio, Pasquale, Stefano Luisi, Moataza Bashir, et al.. (2007). High Urinary Concentrations of Activin A in Asphyxiated Full-Term Newborns with Moderate or Severe Hypoxic Ischemic Encephalopathy. Clinical Chemistry. 53(3). 520–522. 32 indexed citations
20.
Darmstadt, Gary L., Nadia Badrawi, Paul A. Law, et al.. (2004). Topically Applied Sunflower Seed Oil Prevents Invasive Bacterial Infections in Preterm Infants in Egypt. The Pediatric Infectious Disease Journal. 23(8). 719–725. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Okan Özcan Breakdown of academic impact, for papers by Thomas R. Boggs Breakdown of academic impact, for papers by J. P. Farriaux Breakdown of academic impact, for papers by Juan J. Gershanik Breakdown of academic impact, for papers by Swasti Chaturvedi Breakdown of academic impact, for papers by Rajiv Goel Breakdown of academic impact, for papers by Alejandro Pérez‐Muñuzuri Breakdown of academic impact, for papers by Eva Mildenberger Breakdown of academic impact, for papers by Jens Drube Breakdown of academic impact, for papers by Anne Vierzig
Rankless by CCL
2026